La Jolla Diagnostics Inc. Posts Technical Data On New TB Test
LA JOLLA, Calif.--(BW HealthWire)--Sept. 9, 1998--La Jolla Diagnostics Inc. (OTC BB:LAJD), announced last week that it had signed agreements to form a subsidiary and purchase the assets and technology of ATS Inc., a privately held company.
These assets include a proprietary, patent pending rapid diagnostic test for active tuberculosis. The accuracy and efficiency of this TB test has been confirmed in three separate clinical trials, and it is currently approved for sale in several countries with approvals pending in numerous others.
In addition, a major Japanese pharmaceutical company, having completed its own testing, is in the process of registering the product with the Japanese Ministry of Health.
Don Brucker, chief executive officer of La Jolla Diagnostics stated at the time that he was very excited about the transaction. The diagnostic test for TB ia a unique breakthrough product for a disease which is a major problem in many countries, and is becoming a problem in certain areas of the U.S. because of drug resistant strains.
The World Health Organization (WHO) projects that a total of 1 billion TB tests will be performed annually by the year 2000, and presently there is no other test available that can rapidly determine the if the disease is in an active state.
La Jolla Diagnostics has now posted the technical data, including the results of clinical testing, on this rapid (three minute)for active TB test on its Web page at lajd.com.
La Jolla Diagnostics is an emerging company engaged in the development and marketing of diagnostic tests, health care products and nutraceuticals. The health care and nutraceutical products are formulated using a patented clustered water technology.
-U.S. patent 5711950
------------------------------------------------------------------------
Contact:
La Jolla Diagnostics Inc.
800/454-6790, Fax 619/454-7851
lajd96@aol.com
lajd.com
------------------------------------------------------------------------
More Quotes and News:La Jolla Diagnostics Inc (OTC BB:LAJD - news)Related News Categories: biotech |
